Regardless of Anti‐IgG or Anti‐PD‐1 treatment, Anta‐137463 treatment increased the staining level of INSIG1 and reduced the level of SREBP2 in serial sections of xenograft tumor tissues (Figure 7F). Here, SREBF2 is linked to neoplasm.